Denali Therapeutics (DNLI) Net Equity Issued and Repurchased (2017 - 2026)
Denali Therapeutics (DNLI) posted quarterly Net Equity Issued and Repurchased of $12.4 million for Q1 2026, up 102.48% quarter-over-quarter from -$499.3 million in Q4 2024.
Powered by 
Analysis
Denali Therapeutics (DNLI) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $12.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $12.4 million (up 102.48% YoY), while the FY2022 annual figure was $296.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased climbed to $12.4 million in Q1 2026 per DNLI's latest filing, from -$499.3 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $499.3 million in Q1 2024 and bottomed at -$499.3 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Denali Therapeutics | 4.18 Bn | 4.18 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12.37 Mn |
| Dec 31, 2025 | 189.25 Mn |
| Dec 31, 2024 | -499.25 Mn |
| Mar 31, 2024 | 499.25 Mn |
| Mar 31, 2020 | 193.95 Mn |
| Dec 31, 2018 | -94.41 Mn |
| Mar 31, 2018 | 94.41 Mn |
| Dec 31, 2017 | 265.62 Mn |